| This is the talk page for discussing improvements to the Daclizumab article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Daclizumab.
|
Out of date edit
Article seems inconsistent, probably because some parts are now out of date. A chronological History section might help. Rod57 (talk) 09:58, 12 October 2010 (UTC)
contraindications edit
Removed section, was misleading that this drug is contraindicated in breast feeding women. Manufacturer statement cited but this is a legal cover not based on data. No data on this drug being excreted in human breast milk exists and if it is excreted into breast milk risk to fetus is not likely. — Preceding unsigned comment added by Qauz (talk • contribs) 19:06, 1 June 2015 (UTC)